Background: Endothelial colony forming cells (ECFCs) are cultured endothelial cells derived from peripheral blood. ECFCs are a powerful tool to study pathophysiological mechanisms underlying vascular diseases, including von Willebrand disease. In prior research, however, large variations between ECFC lines were observed in, among others, von Willebrand factor (VWF) expression.
| INTRODUC TI ON
von Willebrand factor (VWF) is a large multimeric glycoprotein required for hemostasis. Generally, VWF is known as carrier protein for coagulation factor VIII and as mediator for platelet adhesion and aggregation at sites of vascular damage. More recently, other functions of VWF on the cellular level are described, for example in the process of angiogenesis. 1 Dysfunction or deficiencies of VWF lead to von Willebrand disease (VWD), the most common inherited bleeding disorder. 2 VWF is mainly synthesized in endothelial cells and stored in Weibel-Palade bodies. 3 A small proportion of VWF is produced in megakaryocytes, and stored in their alpha-granules. 4 The pathophysiology of VWD has historically been studied on a cellular level in heterologous cell systems by overexpression of VWF variants. 5, 6 Yet, several aspects of VWF biology (i.e., the process of angiogenesis and VWF behavior under flow) can only be studied in endothelial cells. Moreover, because endothelial cells are the main source of VWF production, it is of utmost importance to study these cells in great detail to understand cellular defects in VWF to benefit VWD patients.
Obtaining endothelial cells from patients or healthy subjects used to be difficult because of the type of tissue needed for endothelial cell isolations. The source of endothelial cells mostly used is the umbilical vein, yielding human umbilical vein endothelial cells (HUVECs).
However, the experimental use of HUVECs is limited because they cannot be obtained from subjects with specific clinical or genetic characteristics. Nowadays, endothelial cells can be isolated from the mononuclear cell fraction from peripheral blood and have the ability to expand ex vivo. 7, 8 Cultured endothelial cells derived from peripheral blood have adopted different names in literature, such as blood outgrowth endothelial cells, late outgrowth endothelial cells or endothelial colony forming cells (ECFCs). 9 Recently, consensus was made to use the term ECFC and we will therefore adapt to this consensus. We would like to highlight that the ECFCs in this study are the same type of cells as the cells denoted as blood outgrowth endothelial cells used in prior studies published by us and most groups studying VWD pathophysiology. [10] [11] [12] In the past decade, multiple studies showed interesting results applying ECFCs to study VWD pathophysiology at the cellular level. [10] [11] [12] [13] [14] [15] Unfortunately, these studies also showed a wide range of variation in the endothelial cells from VWD patients complicating interpretation and comparison of the results. 16 To confidently use ECFCs to study VWD pathophysiology, we need to understand the extent of these variations and their effects on VWF-related parameters; therefore we aim to understand the relation between the phenotypic characteristics and VWF-related parameters of ECFCs from healthy controls. We cultured ECFC lines and investigated their phenotypic characteristics in a standardized setup. The phenotypic characteristics of individual ECFC lines were correlated with VWF parameters and their angiogenic capacity. In addition, gene expression of specific pathways was investigated to unravel the potential underlying mechanism of ECFC variability.
| MATERIAL S AND ME THODS

| ECFC isolation
ECFCs were isolated according to Martin-Ramirez et al (2012) . 17 In short, 30-80 mL peripheral blood was drawn in 10 mL trisodium citrate tubes (ECFCs 1 and 2; S-Monovette ® #02.1067.001, Sarstedt, Nümbrecht, Germany) or 10 mL lithium heparin tubes (ECFCs 3-6; BD Biosciences Vacutainer #367880, BD, Erebodegem, Belgium). Peripheral blood was diluted 1:1 with phosphate-buffered saline (PBS) and blood components were separated by gradient centrifugation over Ficoll Paque (LUMC Pharmacy, Leiden, the Netherlands). The mononuclear cell fraction was isolated and washed 1× in PBS and 1× in 5 mL EGM-20 culture medium, consisting of 500 ml EBM™-2 medium (Lonza, Breda, the Netherlands) supplemented with the EGM™-2 BulletKit™ (Lonza), 100 mL fetal bovine serum (Gibco ® , Invitrogen, Carlsbad, CA), and 7 mL Antibiotic Antimycotic solution (Sigma-Aldrich #A5955, St. Louis, MO). Cells were seeded on 48 wells Nunc™ Cell-Culture Treated Multidishes (Nunclon, Roskilde, Denmark) pre-coated with 50 μg/ mL rat tail collagen type I (BD Biosciences). Medium was refreshed every other day. Cells were passaged according to the scheme in Figure S1A .
The study protocol was approved by the Leiden University Medical Center ethics review board. Informed consent was obtained from all subjects in accordance with the Declaration of Helsinki.
| ECFC culture
ECFCs were cultured in EGM-20 culture medium, which was refreshed every other day. All experiments were performed on cells that were 3-5 days confluent. Cells were considered confluent when they stopped expanding as determined by the cell number per mm 2 (maximum cell density). Cell density was determined by the ITCN plug-in (v1.6) of Fiji, ImageJ (ImageJ 1.51r, Bethesda, MD) on bright-field images that were taken daily. Each single ECFC line at passage 5 was simultaneously subjected to FACS analysis, gene expression analysis and tube formation analysis on Matrigel ( Figure   S1B ). Immunofluorescent staining and VWF antigen (VWF:Ag)
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• Variations in ECFC lines are dependent on the age and mesenchymal state of the cells. measurements were performed in separate experiments ( Figure   S1C ). The characterization of each ECFC line was performed in two independent experiments, except for fluorescence activated cell sorting analysis (FACS) analysis, which was performed once for each ECFC line. 
| FACS analysis
| VWF:Ag measurements
Basal VWF secretion was determined by the release of VWF over 24 hours in EGM-20 culture medium. For determination of intracellular VWF, cells were lysed overnight at 4°C in Opti-MEM™ I Reduced Serum Medium (Thermo Fisher Scientific, Carlsbad, CA) containing 0.1% Triton X-100 (Sigma-Aldrich) supplemented with cOm-plete™ Protease Inhibitor Cocktail with EDTA (Roche Diagnostics, Mannheim, Germany). VWF:Ag levels were measured in conditioned medium and cell lysates by ELISA as previously described. 18 
| Confocal immunofluorescence microscopy
ECFCs were plated on rat tail collagen (50 μg/mL) coated glass coverslips. Three different staining procedures were used to detect intraand/or extracellular VWF. Solely intracellular VWF was visualized after fixation and permeabilization with ice-cold methanol, after which the cells were washed twice with PBS and blocked with PBS, 1% fetal bovine serum (Gibco) and 1% bovine serum albumin (Sigma-Aldrich).
Intra-as well as extracellular VWF was visualized after fixation with 4% paraformaldehyde (Alfa Aesar, Karlsruhe, Germany), after which the cells were washed once and blocked and permeabilized with PBS, 5% normal goat serum (DAKO, Glostrup, Denmark) and 0.02% saponin (Sigma-Aldrich). Extracellular VWF was visualized after fixation with 4% paraformaldehyde, after which the cells were washed once and blocked with PBS and 5% normal goat serum (DAKO). Cells were stained for VWF with polyclonal antibody rabbit anti-hVWF (A0082, DAKO) and for VE-cadherin with purified mouse anti-human CD144 (BD Biosciences) diluted in the corresponding blocking buffer. Nuclear staining was performed with Hoechst (Thermo Fisher Scientific) diluted in PBS. Coverslips were mounted by ProLong ® Diamond Antifade Mountant (Thermo Fisher Scientific) and cells were visualized by the Leica TCS SP8 X WLL converted confocal microscope equipped with a HC PL APO CS2 63×/1.40 OIL immersion objective.
| Matrigel tube formation
Ninety-six wells plates were coated with 46 μL/well growth factor reduced Matrigel (BD Biosciences) for 1 hour at 37°C. ECFCs were seeded on the Matrigel at a concentration of 15 000 cells per well in EGM-2 medium. The culture plate was placed in a Leica DMI6000 inverted microscope with an environmental chamber for control of temperature (37°C) and CO 2 concentration (5%). Images were taken every 15 minutes with a 10× magnification using a LEICA DF350FX CCD camera until 24 hours after seeding cells. Analysis were performed with Fiji (ImageJ) using the Angiogenesis Analyzer plugin (version 1.0c). Two independent experiments were performed in triplicate for each ECFC line. Average values of triplicates were calculated for the tube length, number of branches, and number of meshes as characteristics of each ECFC line.
| Gene expression
RNA was isolated using the RNeasy Micro Kit (Qiagen, Venlo, the Netherlands). Complementary DNA was synthesized using SuperScript™ II Reverse Transcriptase (Thermo Fisher Scientific) with poly(T) primers (Sigma-Aldrich). Quantitative PCR (qPCR) was performed using Sybr™ Select Master Mix (Thermo Fisher Scientific) in the CFX384 Touch instrument (Bio-Rad, Veenendaal, the Netherlands) with GAPDH as endogenous reference gene. Table   S1 shows sequences of gene specific primers. The comparative Ct method was used as described by Wong and Medrano. 19 
| Statistics
GraphPad Prism, version 7.00 (GraphPad Software, La Jolla, CA), was used for graphics and statistical analysis. Pearson correlation was used to determine the strength of association between cell density and all other measured parameters. Significance was set at P < .05 (two-tailed).
| RE SULTS
| Phenotypic characterization
ECFCs were isolated from six healthy donors which resulted in the outgrowth of 16 ECFC lines. In isolations of some donors, several clones appeared and these lines were cultured separately (for example, for donor 4, these multiple clones were named ECFC line 4A, 4B, etc.), so we could study both inter-and intra-donor variability. All ECFCs were positive for endothelial markers CD31 and CD146 and negative for leukocyte markers CD14 and CD45; however, a subset of ECFC lines showed decreased positivity for CD144 suggesting a mixed population ( Figure 1A , all histograms in Figure S2 ). Furthermore, remarkable differences were observed between cell sizes at maximum confluency and morphology of the different lines ( Figure 1B and Figure S3 ) and we observed that cell lines with bigger cell sizes have a more mesenchymal phenotype and could reach a lower cell density at maximum confluency. These "low cell density" ECFC lines are the lines with decreased positivity for CD144 ( Figure 1C ). Because we would like to show the characteristics of all cell populations that appear after ECFC isolation, we did not exclude cells for which the ECFC identity may be less clear because of lower CD144 positivity (i.e., ECFCs 1, 2, 6A, 6C, and 6E).
| VWF:Ag measurements
To evaluate the optimal timepoint to perform experiments, seven proliferative ECFC lines were subconfluently plated and followed over time for secreted VWF:Ag levels and cell density (bright-field images of three representative cell lines in Figure S4 ). Maximum VWF:Ag levels were measured in conditioned medium 3-5 days after the ECFCs stopped expanding (maximum cell density). Both secreted VWF:Ag levels, and cell density remained constant after the maximum density was reached ( Figure 2A) ; therefore, all experiments in this study were performed at this stable phase, 3-5 days after the cells stopped expanding. The results for VWF secretion and cell density were comparable to observations in HUVECs. 20, 21 To determine differences in VWF:Ag secretion between the different ECFC lines, VWF:Ag levels released in 24 hours were measured in conditioned medium at maximum cell density. Interestingly, we observed a significant correlation between secreted VWF:Ag levels and maximum cell density, where cell lines with a high maximum cell density secreted more VWF than lines with a low maximum cell density (R 2 = .89, P = .0001; Figure 2B ). A correlation between secreted VWF:Ag levels and cell density is also observed in the days before maximum cell density; however, the slope of the lines is lower and increases until the day we measure highest VWF:Ag level. This slope remained constant from that moment on, just as the VWF:Ag levels did (data not shown). All separate clones were analyzed as independent data points, but a significant correlation between VWF:Ag secretion and maximum cell density was still present when all clones of a single donor were pooled. ECFC lines with a maximum cell density below 500 cells/mm 2 (ECFCs 1, 2, and 6A-E) had a VWF:Ag secretion below the lower limit of detection and were therefore excluded in the correlation analysis. The fold increase of VWF release in 1 hour after histamine stimulation over the release in 1 hour in unstimulated cells (the stimulation factor) was similar for To exclude that cells with a high maximum cell density have a higher secretion rate and therefore lower intracellular VWF:Ag levels, we measured total VWF:Ag levels in conditioned medium and cell lysates. However, total VWF:Ag production also significantly correlated with maximum cell density (R 2 = .96, P < .0001; Figure 2C ).
Because the total VWF:Ag level per individual cell was also higher in smaller cells, we excluded that higher VWF:Ag levels were measured because of the presence of a higher number of cells ( Figure 2D ). Also, on the mRNA level, a significant correlation was observed between maximum cell density and VWF (R 2 = .63, P = .0002; Figure 2E ).
Different clones that were isolated from individual donors also show variations in maximum cell density ( Figure 2F ) and VWF:Ag expression ( Figure 2G ) and we therefore subsequently analyzed all ECFC lines as individual clones.
Passaging of endothelial cells can result in morphological changes 22 ; therefore, maximum cell density and VWF:Ag secretion at increasing passage numbers were studied. Two ECFC lines (4B and 5A) were passaged until they stopped proliferating at passage number 15 and 12, respectively. Both lines showed a decrease in maximum cell density with increasing passage number, which correlated with decreased secreted VWF:Ag levels ( Figure 2H and I) .
Furthermore, the ECFC line with the highest maximum cell density (4B) could be passaged until a higher passage number compared to the ECFC line with a lower maximum cell density (5A).
Overall, VWF production correlate with maximum ECFC density. This is observed both in cells at similar passage numbers and in cells with increasing passage numbers.
| VWF localization
Endothelial cells store VWF in Weibel-Palade bodies. 3 To investigate whether the ECFC lines were able to store VWF in Weibel-Palade bodies, all ECFC lines were stained for VWF and endothelial marker VE-cadherin. Although all ECFC lines showed VWF in Weibel-Palade bodies, large differences were observed in staining patterns ( Figure 1B for representative examples, all data in Figure S3 ). ECFC lines with a very high maximum cell density (4A and 4B) showed mainly VWF staining closer to the cell membrane. Also, strings of released VWF were observed in some of these cell lines, whereas the cells were not extrinsically stimulated to secrete VWF ( Figure   S3 , 
| Matrigel tube formation
Compared with the normal population, an increased number of VWD patients suffer from intestinal bleeding caused by angiodysplasia. 23 Several studies have shown a negative correlation of VWF and angiogenesis and VWF downregulation in an in vitro small interfering RNA knockdown assay resulted in increased angiogenic capacity. 12, 13, 24 We therefore reasoned that ECFC lines with low VWF production might have higher angiogenic potential than ECFC lines with high VWF production. 24 The angiogenic properties of all 16 ECFC lines were investigated in an in vitro Matrigel tube formation assay. Herewith, the ability of endothelial cells to form tube-like structures was investigated, involving endothelial cell adhesion and migration. The formation of tube-like structures of all ECFC lines was followed for 24 hours.
Although the angiogenic capacity clearly differed between ECFC lines ( Figure S3 ), the maximum tube length ( Figure 3A ) and maximum number of branches, meshes, and junctions (data not shown) were mostly reached between 2 and 6 hours after seeding the cells. After maximum levels were reached, the cells migrated to form cell clumps for low maximum cell density ECFC lines or structures were destroyed in case of high maximum cell density ECFC lines; therefore, we used the average of the maximum value and the four adjacent values of each parameter in all analyses. Significant correlations with maximum cell density and maximum tube length (R 2 = .72, P < .0001; Figure 3B ), maximum number of meshes (R 2 = .60, P < .001; Figure 3C ) and maximum number of branches (R 2 = .75, P < .0001; Figure 3D) were observed. Overall, the maximum cell density of ECFCs show a negative correlation with the angiogenic capacity.
Gene expression of the angiogenic markers angiopoietin-2 (ANGPT2), CD34, CD105 (endoglin), and VEGF receptor-2 (or kinase insert domain receptor, KDR) was evaluated to investigate the underlying mechanism for the observed variations. No correlation was detected between maximum cell density and CD34 or CD105 expression (data not shown). Interestingly, ANGPT2 (R 2 = .42, P < .01; Figure 3E ) and KDR (R 2 = .66, P = .0001; Figure 3F ) expression significantly correlated with maximum cell densities, with higher levels of ANGPT2 in cell lines with high maximum cell densities and higher levels of KDR in lines with lower maximum cell densities. SOX18 is described to be higher in early passage ECFCs, whereas CXCL8 is higher in ECFCs close to their Hayflick limit. 22 CXCL8 is also described as a modulator of senescence, and its gene expression significantly correlates with β-galactosidase and γH2AX stainings. 22 We confirm the influence of aging on the variations seen in the ECFC lines by significant correlations between maximum cell density and gene expression of CXCL8 (R 2 = .84, P < .0001; Figure 4A ) and SOX18 (R 2 = .79, P < .0001; Figure 4B ). A lower expression of CXCL8 and a higher expression of SOX18 was detected in lines with a high maximum cell density. The inverse was true for lines with a low maximum cell density.
| Gene expression of aging and endothelial to mesenchymal transition markers
ECFC lines with a lower maximum cell density showed loss of cell-cell interactions and loss of the typical cobblestone morphology, observations that correlate with a mesenchymal-like phenotype. Transition of endothelial cells to a more mesenchymal phenotype is described as endothelial to mesenchymal transition (EndoMT). In EndoMT, gene expression of endothelial markers is reduced, whereas an induction in expression of extracellular matrix proteins becomes apparent. 25, 26 We observed significant negative correlations between maximum cell density and mesenchymal marker α-smooth muscle actin (ACTA1, R 2 = .81, P < .0001; Figure 4C ) and significant positive correlations between maximum Figure 4D ). Collagen Type I Alpha 1
Chain (COL1A1; Figure 4E ) showed especially high expression levels in cell lines with a low maximum cell density (<500 cells/ Figure 4F ), wherein ECFC lines with smaller cells expressed higher levels of KLF2. The same was true when correlating ECFC density with EFNB2 (R 2 = .86, P < .0001; Figure 4G) and THBD (R 2 = .82, P < .0001; Figure 4H ).
Overall, gene expression of senescence and EndoMT markers negatively correlate with ECFC density, whereas shear stress markers positively correlate with ECFC density. we could not detect VWF by ELISA. We did not exclude these cells from most analysis because we aimed to show the characteristics of all cell lines that appear after the isolation procedure. However, it is questionable whether cells with a maximum cell density <500 cells/ mm 2 and decreased CD144 expression are true endothelial cells (even though these cells are CD14 and CD45 negative and CD31 and CD146 positive) or are a mixed population. We therefore suggest, based on the results shown in this study, not to use these cells in VWF/VWD research. However, when studying specific patients with a unique clinical phenotype, one may have to accept that the patient-derived ECFCs have a mixed phenotype. When "suboptimal" patient-derived clones with a mixed phenotype appear, it is then of utmost importance to compare these cell lines with an appropriate, and if necessary a mixed control.
| D ISCUSS I ON
The effects of passaging of ECFCs was determined in two ECFC lines and we observed a decrease in maximum cell density and VWF production every time a cell line was passaged. Furthermore, the ECFC line with the smallest cells and therefore highest maximum cell density (ECFC 4B) could reach a higher passage number than the ECFC line with the bigger cells and lower maximum cell density (ECFC 5A). The passage number indicates the number of times a cell line has been trypsinized and subcultured ( Figure S1 ), but is not to be confused with the population doubling level, which is the number of times a cell has doubled since the primary isolation. Because ECFC 4B has a higher maximum cell density than ECFC 5A, the exact number of cell doublings that can be reached for ECFC 4B is even higher than the passage number indicates compared with ECFC 5A.
Furthermore, passaging of cells also led to decreased maximum cell density and VWF production, which indicates that one single ECFC line can have different cellular characteristics.
An increased percentage of VWD patients compared to the normal population develop intestinal bleeding caused by angiodysplasia. 27 This is the result of increased angiogenesis, a process that in vitro can be simulated by a Matrigel tube formation assay. Although ECFCs proved to be a strong tool to study angiogenesis ex vivo, the exact role of VWF in angiogenesis remains unclear. Most importantly, small interfering RNA-mediated downregulation of VWF in HUVECs led to increased Matrigel tube formation. 24 We showed clear variations in angiogenic capacity between healthy control ECFCs with increased angiogenic capacity in lines with low VWF production compared with lines with high VWF production. It is important to acknowledge these inter-clonal variations in healthy con- CXCL8 and SOX18, suggesting that cell lines with a low maximum cell density are more senescent than cells with a high maximum cell density. This is an interesting observation because ECFCs with a low maximum cell density have bigger cells and therefore had less cell doublings in culture than ECFC lines with a high maximum cell density at the same passage number. A possible explanation could be that the cells from which the ECFC lines originate vary in their senescent state or that the cells have a different origin (i.e., tissue-specific or bone-marrow derived); however, more research is necessary to confirm this. 30 Although more markers are needed to fully define senescence, we highlight with these markers differences between cell lines.
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EndoMT was studied as possible explanation for the variations because low maximum cell density lines had a more mesenchymal phenotype with loss in cell-cell contacts. We confirmed a more mesenchymal phenotype in low-density lines by gene expression analysis of mesenchymal markers ACTA1, VIM, and COL1A1. EndoMT could be induced by shear stress 31 ECFCs to match patient-derived ECFCs with control ECFCs. Also, it is important to take maximum cell density into account and to perform experiments 3-5 days after the cells stop expanding. We also suggest synchronization and standardization of the experiments between laboratories to fairly compare results. This is especially a necessity when sample sizes are small as they are in VWD research.
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